Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Operating Expenses (2022 - 2025)

Core Laboratories' Operating Expenses history spans 4 years, with the latest figure at $14.2 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 12.82% year-over-year to $14.2 million; the TTM value through Dec 2025 reached $59.7 million, up 10.15%, while the annual FY2025 figure was $59.7 million, 10.15% up from the prior year.
  • Operating Expenses reached $14.2 million in Q4 2025 per CLB's latest filing, roughly flat from $14.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $17.2 million in Q1 2025 to a low of $3.7 million in Q4 2023.
  • Average Operating Expenses over 4 years is $9.4 million, with a median of $12.2 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: decreased 9.12% in 2023, then surged 293.6% in 2024.
  • A 4-year view of Operating Expenses shows it stood at $3.9 million in 2022, then decreased by 4.05% to $3.7 million in 2023, then skyrocketed by 236.89% to $12.6 million in 2024, then grew by 12.82% to $14.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Operating Expenses are $14.2 million (Q4 2025), $14.2 million (Q3 2025), and $14.0 million (Q2 2025).